Literature DB >> 29759004

Is There a Delay in Diagnosis of Duchenne Muscular Dystrophy Among Preterm-Born Males?

Aida Soim1, Michael G Smith2, Jennifer M Kwon3, Joshua R Mann4, Shiny Thomas1, Emma Ciafaloni3.   

Abstract

The objective of this study was to investigate whether males who were born preterm took longer to receive a Duchenne muscular dystrophy diagnosis than term males. Data for males with Duchenne muscular dystrophy identified through a population-based surveillance system were analyzed using a Kaplan-Meier estimator. The first signs and symptoms were noted at a median age of 2 years in both groups. Median age when first signs and symptoms prompted medical evaluation was 2.59 years among preterm and 4.01 years among term males. Median age at definitive diagnosis was 4.25 years and 4.92 years for preterm and term males, respectively. Neither difference was statistically significant. Preterm males tended to be seen for their initial medical evaluation earlier than term males, though they were not diagnosed significantly earlier. It may take clinicians longer after the initial evaluation of preterm males to arrive at a Duchenne muscular dystrophy diagnosis.

Entities:  

Keywords:  Duchenne muscular dystrophy; children; epidemiology; pediatric; preterm

Mesh:

Year:  2018        PMID: 29759004      PMCID: PMC5995644          DOI: 10.1177/0883073818773029

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  16 in total

Review 1.  Evidence report: Genetic and metabolic testing on children with global developmental delay: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society.

Authors:  D J Michelson; M I Shevell; E H Sherr; J B Moeschler; A L Gropman; S Ashwal
Journal:  Neurology       Date:  2011-09-28       Impact factor: 9.910

2.  Diagnostic delay in Duchenne's muscular dystrophy.

Authors:  D E Crisp; F A Ziter; P F Bray
Journal:  JAMA       Date:  1982 Jan 22-29       Impact factor: 56.272

3.  The muscular Dystrophy Surveillance Tracking and Research Network (MD STARnet): surveillance methodology.

Authors:  Lisa A Miller; Paul A Romitti; Christopher Cunniff; Charlotte Druschel; Katherine D Mathews; F John Meaney; Dennis Matthews; Jiji Kantamneni; Zhen-Fang Feng; Nancy Zemblidge; Timothy M Miller; Jennifer Andrews; Deborah Fox; Emma Ciafaloni; Shree Pandya; April Montgomery; Aileen Kenneson
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2006-11

Review 4.  Delayed diagnosis of Duchenne muscular dystrophy.

Authors:  K Mohamed; R Appleton; P Nicolaides
Journal:  Eur J Paediatr Neurol       Date:  2000       Impact factor: 3.140

5.  The incidence of Duchenne muscular dystrophy in eastern Austria. The controversy regarding CK screening.

Authors:  E Hauser; K Toifl; A Mad; R Bittner
Journal:  Wien Klin Wochenschr       Date:  1993       Impact factor: 1.704

6.  Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals.

Authors:  M Koenig; E P Hoffman; C J Bertelson; A P Monaco; C Feener; L M Kunkel
Journal:  Cell       Date:  1987-07-31       Impact factor: 41.582

Review 7.  Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management.

Authors:  Katharine Bushby; Richard Finkel; David J Birnkrant; Laura E Case; Paula R Clemens; Linda Cripe; Ajay Kaul; Kathi Kinnett; Craig McDonald; Shree Pandya; James Poysky; Frederic Shapiro; Jean Tomezsko; Carolyn Constantin
Journal:  Lancet Neurol       Date:  2009-11-27       Impact factor: 44.182

Review 8.  Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care.

Authors:  Katharine Bushby; Richard Finkel; David J Birnkrant; Laura E Case; Paula R Clemens; Linda Cripe; Ajay Kaul; Kathi Kinnett; Craig McDonald; Shree Pandya; James Poysky; Frederic Shapiro; Jean Tomezsko; Carolyn Constantin
Journal:  Lancet Neurol       Date:  2009-11-27       Impact factor: 44.182

9.  Delay in diagnosing Duchenne muscular dystrophy in orthopaedic clinics.

Authors:  L Read; C S Galasko
Journal:  J Bone Joint Surg Br       Date:  1986-05

10.  Delay in Diagnosis of Duchenne Muscular Dystrophy.

Authors:  Vamshi K Rao; Nancy L Kuntz
Journal:  Pediatr Neurol Briefs       Date:  2015-01
View more
  1 in total

1.  Genotype characterization and delayed loss of ambulation by glucocorticoids in a large cohort of patients with Duchenne muscular dystrophy.

Authors:  Shu Zhang; Dongdong Qin; Liwen Wu; Man Li; Lifang Song; Cuijie Wei; Chunling Lu; Xiaoli Zhang; Siqi Hong; Mingming Ma; Shiwen Wu
Journal:  Orphanet J Rare Dis       Date:  2021-04-28       Impact factor: 4.123

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.